Reverse Medical Corporation Announces Strategic Alliance in Japan

  Reverse Medical Corporation Announces Strategic Alliance in Japan

Business Wire

IRVINE, Calif. -- June 11, 2013

Reverse Medical Corporation today announced entering into a strategic
partnership agreement with Century Medical, Inc. (CMI), for distribution of
the Reverse Medical products in Japan. CMI (a subsidiary of ITOCHU
Corporation) is the premiere medical device product distributor in Japan.
Commenting on the Agreement, Reverse Medical President & CEO Mr. Jeffrey Valko
stated, “We are extremely pleased to have CMI as our strategic partner. The
depth and strength of CMI’s network throughout Japan will greatly assist
Reverse Medical in developing a leadership role in treating patients with
complex Neurovascular disorders. CMI has made a significant financial
commitment to both Reverse, and to funding the regulatory approval process for
the Reverse products in Japan, and will concentrate on moving Reverse’s
Barrel™ Vascular Reconstruction Device (VRD), Micro Vascular Plug (MVP™)
embolization device, and Reverse’s other products through the Japanese
regulatory approval process. We continue to actively develop similar
partnerships for European distribution of our products.”

Nobuyuki Sakai, MD (Kobe, Japan) stated, "Reverse Medicalhas developed
several unique and useful technologies for Neuro interventional procedures.I
am pleased by CMI’s recognition of the innovative and unique differentiating
value of the Reverse technologies, and the promise for significant market
adoption in Japan.”

CMI President & CEO Mr. Akira Hoshino added, “We are truly impressed by the
ongoing innovation from Reverse Medical and the speed with which they’ve
achieved product development, regulatory approvals and successful human
clinical experience. CMI believes the Japanese market for unique products to
treat patients with complex neurovascular conditions remains vastly
under-penetrated, with significant opportunity for advanced technology
adoption and growth.” CMI and Reverse Medical are progressing through various
milestones toward regulatory approvals from the Japanese Ministry of Health,
Labor and Welfare approvals.

Reverse Medical Corporation, based in Irvine, California, is a privately held
medical device company focused on expanding the endovascular management of
peripheral and neurovascular disease. The technology pipeline includes
innovative, state-of-the-art treatments for a broad spectrum of peripheral and
neurovascular disorders and disease.


Reverse Medical Corporation
Jeffrey Valko, President & CEO
949-215-0660, ext. 200
Press spacebar to pause and continue. Press esc to stop.